Alliant proposes $3 billion in new wind energy in Iowa as Congress set to phase out tax credits that helped state become a ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get ...